B-cell-specific checkpoint molecules that regulate anti-tumour immunity-Reference-Cited by-同舟云学术

B-cell-specific checkpoint molecules that regulate anti-tumour immunity

Published:2023-06-21 Issue:7969 Volume:619 Page:348-356
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Bod Lloyd,Kye Yoon-Chul^ORCID,Shi Jingwen,Torlai Triglia Elena^ORCID,Schnell Alexandra^ORCID,Fessler Johannes,Ostrowski Stephen M.,Von-Franque Max Y.^ORCID,Kuchroo Juhi R.,Barilla Rocky M.^ORCID,Zaghouani Sarah^ORCID,Christian Elena,Delorey Toni Marie^ORCID,Mohib Kanishka^ORCID,Xiao Sheng,Slingerland Nadine^ORCID,Giuliano Christopher J.^ORCID,Ashenberg Orr,Li Zhaorong^ORCID,Rothstein David M.^ORCID,Fisher David E.,Rozenblatt-Rosen Orit^ORCID,Sharpe Arlene H.^ORCID,Quintana Francisco J.^ORCID,Apetoh Lionel^ORCID,Regev Aviv^ORCID,Kuchroo Vijay K.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-023-06231-0.pdf

Reference71 articles.

1. Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443–2454 (2012).

2. Wolchok, J. D. et al. Nivolumab plus ipilimumab in advanced melanoma. N. Engl. J. Med. 369, 122–133 (2013).

3. Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812–830 (2018).

4. Griss, J. et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat. Commun. 10, 4186 (2019).

5. Ladanyi, A. et al. Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunol. Immunother. 60, 1729–1738 (2011).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of tertiary lymphoid structure and B cells in nasopharyngeal carcinoma: Based on bioinformatics and experimental verification;Translational Oncology;2024-03

2. Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications;Frontiers in Immunology;2024-01-30

3. Antitumor effects of TIM‐1 blockade in B cells;MedComm – Future Medicine;2024-01-29

4. Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control;PLOS Pathogens;2024-01-25

5. Combining RAS^G12C(ON) inhibitor with SHP2 inhibition sensitises immune excluded lung tumours to immune checkpoint blockade: a strategy for turning cold tumours hot;2024-01-16